tradingkey.logo

RDGT

RDGT
3.570USD
+0.010+0.28%
Close 12/19, 16:00ETQuotes delayed by 15 min
20.90MMarket Cap
1.94P/E TTM

More Details of Ridgetech Inc Company

Ridgetech Inc, formerly China Jo-Jo Drugstores Inc, is a retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors.

RDGT Info

Ticker SymbolRDGT
Company nameRidgetech Inc
IPO dateApr 14, 2008
CEOLiu (Lei)
Number of employees61
Security typeOrdinary Share
Fiscal year-endApr 14
Address4Th Floor, Building 5, Renxin Yaju
CityHANGZHOU
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code310014
Phone8657188219579
Websitehttp://www.jiuzhou360.com
Ticker SymbolRDGT
IPO dateApr 14, 2008
CEOLiu (Lei)

Company Executives of RDGT

Name
Name/Position
Position
Shareholding
Change
Mr. Ming (Frank) Zhao
Mr. Ming (Frank) Zhao
Chief Financial Officer
Chief Financial Officer
581.00
-82.56%
Dr. Genghua Gu
Dr. Genghua Gu
Independent Director
Independent Director
42.00
--
Ms. Li Qi
Ms. Li Qi
Director
Director
--
--
Mr. Jiangliang He
Mr. Jiangliang He
Independent Director
Independent Director
--
--
Ms. Caroline Wang
Ms. Caroline Wang
Independent Director
Independent Director
--
--
Ms. Tina Xiao
Ms. Tina Xiao
Investor Relation
Investor Relation
--
--
Mr. Lei Liu
Mr. Lei Liu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Ming (Frank) Zhao
Mr. Ming (Frank) Zhao
Chief Financial Officer
Chief Financial Officer
581.00
-82.56%
Dr. Genghua Gu
Dr. Genghua Gu
Independent Director
Independent Director
42.00
--
Ms. Li Qi
Ms. Li Qi
Director
Director
--
--
Mr. Jiangliang He
Mr. Jiangliang He
Independent Director
Independent Director
--
--
Ms. Caroline Wang
Ms. Caroline Wang
Independent Director
Independent Director
--
--
Ms. Tina Xiao
Ms. Tina Xiao
Investor Relation
Investor Relation
--
--

Revenue Breakdown

FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
China (Mainland)
119.97M
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Kong (Lingtao)
21.12%
Super Marvel, Ltd.
0.24%
HHLR Advisors, Ltd.
0.19%
Two Sigma Investments, LP
0.14%
Citadel Advisors LLC
0.11%
Other
78.21%
Shareholders
Shareholders
Proportion
Kong (Lingtao)
21.12%
Super Marvel, Ltd.
0.24%
HHLR Advisors, Ltd.
0.19%
Two Sigma Investments, LP
0.14%
Citadel Advisors LLC
0.11%
Other
78.21%
Shareholder Types
Shareholders
Proportion
Individual Investor
21.13%
Hedge Fund
0.24%
Corporation
0.24%
Investment Advisor/Hedge Fund
0.19%
Investment Advisor
0.05%
Other
78.15%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
13
46.41K
0.79%
-17.32K
2025Q2
22
2.31M
37.48%
-294.49K
2025Q1
23
2.31M
37.41%
-295.22K
2024Q4
24
2.57M
38.75%
-505.67K
2024Q3
25
3.05M
45.78%
+2.48M
2024Q2
24
550.07K
18.53%
+436.00K
2024Q1
26
94.32K
7.40%
-18.04K
2023Q4
26
98.71K
7.66%
-15.19K
2023Q3
28
101.29K
7.81%
-20.17K
2023Q2
27
115.01K
9.71%
+15.56K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Kong (Lingtao)
2.23M
38%
--
--
Jul 28, 2025
Super Marvel, Ltd.
25.13K
0.43%
--
--
Nov 14, 2024
HHLR Advisors, Ltd.
20.17K
0.34%
--
--
Jun 30, 2025
Two Sigma Investments, LP
13.12K
0.22%
+1.19K
+9.99%
Jun 30, 2025
UBS Financial Services, Inc.
13.13K
0.22%
+2.82K
+27.40%
Jun 30, 2025
Zhao (Ming)
581.00
0.01%
-2.75K
-82.56%
Jul 28, 2025
Gu (Genghua)
42.00
0%
--
--
Jul 28, 2025
XTX Markets LLC
--
0%
-15.13K
-100.00%
Jun 30, 2025
Oarsman Capital Inc.
--
0%
-80.00
-100.00%
Mar 31, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Feb 28, 2024
Merger
20→1
Date
Type
Ratio
Feb 28, 2024
Merger
20→1

FAQs

Who are the top five shareholders of RDGT?

The top five shareholders of RDGT are:
Kong (Lingtao) holds 2.23M shares, accounting for 38.00% of the total shares.
Super Marvel, Ltd. holds 25.13K shares, accounting for 0.43% of the total shares.
HHLR Advisors, Ltd. holds 20.17K shares, accounting for 0.34% of the total shares.
Two Sigma Investments, LP holds 13.12K shares, accounting for 0.22% of the total shares.
UBS Financial Services, Inc. holds 13.13K shares, accounting for 0.22% of the total shares.

What are the top three shareholder types of RDGT?

The top three shareholder types of RDGT are:
Kong (Lingtao)
Super Marvel, Ltd.
HHLR Advisors, Ltd.

How many institutions hold shares of RDGT (RDGT)?

As of 2025Q3, 13 institutions hold shares of RDGT, with a combined market value of approximately 46.41K, accounting for 0.79% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -36.68%.

What is the biggest source of revenue for RDGT?

In FY2025, the -- business generated the highest revenue for RDGT, amounting to -- and accounting for --% of total revenue.
KeyAI